Surgical management of hydatid cyst disease of the liver: An improvement from our previous experience?

Table 1 Demographic data and concurrent comorbidities in the patient population

Parameter		Laparoscopic, n = 70 (%)	Open approach, n = 170 (%)	P value
Age	Mean age	39.87 ± 14.4	44.36 ± 15.99	0.03
Sex	Male	29 (41.42)	80 (47.28)	0.4
	Female	41 (58.58)	90 (52.72)
Environment	Urban	29 (41.42)	65 (38.04)	0.61
	Rural	41 (58.58)	105 (61.96)
Symptoms	Pain in the RUQ	50 (71.42)	119 (70.1)	0.83
	Biliary dispeptic syndrome	12 (17.14)	40 (23.36)	0.28
	Cutaneous eruption	0 (0)	4 (2.71)	0.16
	Hepatomegalia w/palpable mass	1 (1.42)	7 (4.3)	0.46
Comorbidities	Hypertension	9 (12.85)	32 (19.02)	0.24
	Ischemic cardiopathy	2 (2.85)	14 (8.15)	0.13
	Type II diabetes	4 (5.71)	12 (7.06)	0.78
	Obesity	6 (8.57)	20 (11.9)	0.43
ASA	1 or 2	37 (52.85)	90 (53.2)	0.36
	3	29 (41.42)	68 (40.2)	0.97
	4	4 (5.71)	12 (6.5)	0.95
Hydatid elements in the CBD		6 (8.57)	19 (11.17)	0.34
Median ALT value		45 (25-180)	42 (25-220)	0.88
Median AST value		40 (25-190)	45 (20-225)	0.76

RUQ: Right upper quadrant; CBD: Cannabidiol; ASA: American Society of Anesthesiologists; AST: Aspartate aminotransferase; ALT: Alanine aminotransferase.